KRas and Braf: Is a Predictor in Metastatic Colorectal Cancer Patients for Bevacizumab?

Author
Ozguroglu, M.
Erdamar, S.
Selcukbiricik, F.
Buyukunal, E.
Ozturk, M. A.
Serdengecti, S.
Demir, G.
Mandel, N. M.
Tural, D.
Yildiz, O.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/152855
https://doi.org/10.1016/s0959-8049(11)71665-3
Collections